Dr. Adam D. Comer, MD
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- Indiana University School of Medicine (2012)
- Years since graduation
- 14
- In the NPI registry since
- 2012
- Medicare patients seen, 2024
- 187
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Medical school: Indiana University School of Medicine
- 2012Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
IN license 01076450A -
Clinical Neurophysiology Physician
IN license 01076450A -
Internal Medicine Physician
IN license 11016688 · IN license 01076450A
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Indiana University Health Indianapolis, IN
- Deaconess Hospital Inc Evansville, IN
- Indiana University Health Bloomington Hospital Bloomington, IN
Medical groups
- Iu Health Medical Group LLC (4,462 clinicians)
- Cutting Edge Physical Therapy Limited PArtnership (106 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 187
- Services billed
- 383
- Patients’ average age
- 67
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 67 | 43 |
| Established patient office or other outpatient visit, 20-29 minutes | 36 | 34 |
| Established patient office or other outpatient visit, 30-39 minutes | 32 | 27 |
| Established patient office or other outpatient visit, 40-54 minutes | 28 | 28 |
| Needle measurement of electrical activity in arm or leg muscles, limited study | 25 | 19 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 24 | 24 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 23 | 23 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 19 | 13 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 15 | 15 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 14 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gabapentin Other prescribers in Indianapolis, IN | 92 |
| Mycophenolate Mofetil Other prescribers in Indianapolis, IN | 61 |
| Pregabalin Other prescribers in Indianapolis, IN | 60 |
| Prednisone Other prescribers in Indianapolis, IN | 36 |
| Pyridostigmine Bromide Other prescribers in Indianapolis, IN | 34 |
| Evrysdi (risdiplam) | 29 |
| Emflaza (deflazacort) | 24 |
| Baclofen Other prescribers in Indianapolis, IN | 20 |
| Duloxetine Hcl Other prescribers in Indianapolis, IN | 18 |
| Riluzole | 14 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 3 payments worth $72.00 in total to this clinician.
| Cadwell Industries, Inc | $37.57 |
|---|---|
| Medtronic, Inc. | $34.43 |
| Food and Beverage | $72.00 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $34,839 in research payments for these studies, mostly to the institutions running them.
- A Phase 1/2, Randomized, Double-blind, Placebo?controlled Single- and Multiple?dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VX?670 in Adult Subjects with Myotoni…
Vertex Pharmaceuticals Incorporated
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.